Open Save New
FeedNavigator / National Library of Health Sciences
Tutkijat / Oulu
AddAla-Kokko, L.
AddAla-Kokko, T(ero)
AddAla-Korpela, M(ika)
AddAlahuhta, S.
AddAlen, M.
AddAntikainen, R.
AddAnttonen, V(uokko)
AddBiancari, F.
AddBloigu, R(isto)
AddEskelinen, S.
AddFlinkkilä, T(apio)
AddHakkola, J.
AddHallman, M.
AddHartikainen, A(nna)-L(iisa)
AddHausen, H.
AddHautala, N(ina)
AddHautala, T(imo)
AddHeape, A.
AddHerzig, K(arl)-H(einz)
AddHillbom, M.
AddHiltunen, J.K.
AddHörkko, S.
AddHuikuri, H
AddHukkanen J(anne)
AddIgnatius, J.
AddIsohanni, M.
AddJaakkola, J.
AddJaakkola, M(aritta) S.
AddJaakola, V-P.
AddJämsä, T(imo)
AddJanhonen, S.
AddJärvelin, M(arjo)-R(iitta)
AddJokelainen, J(ari)
AddJuffer, A.H.
AddJunttila, J(uhani)
AddJuvonen, T.
AddKaarteenaho, R(iitta)
AddKajantie, E(ero)*(THL/OY)
AddKarppinen (Koivunen), P(eppi)
AddKarppinen, J(aro)
AddKarttunen, T.J.
AddKeinänen-Kiukaanniemi, S(irkka)
AddKerkelä, R(isto)
AddKesäniemi, Y.A.
AddKettunen, J(ohannes)
AddKietzmann, T(homas).
AddKivirikko, K.I.
AddKnuuttila, M.
AddKoivukangas, J.
AddKursula, P.
AddKyngäs, H.
AddLarivaara, P.
AddLarmas, M.
AddLehenkari, P(etri)
AddLehtiö, L(ari)
AddLeppilahti, J.
AddLuukinen, H.
AddMainio A
AddMajamaa, K.
AddMäki, P(irjo)
AddMäkikallio, T.
AddMännikkö, M(inna)
AddManninen, A(ki).
AddMartikainen, H(annu)
AddMiettunen, J(ouko)
AddMyllyharju, J.
AddMyllylä, R.
AddMyllylä, V.
AddNäyhä, S.
AddNeubauer, P.
AddNieminen, M(iika) T.
AddNieminen, P(entti)
AddNiinimäki, J(aakko)
AddOhukainen, P(auli)
AddOikarinen, A.
AddOikarinen, K.
AddPelkonen, O(lavi)
AddPetäjä-Repo, U.E.
AddPihlajaniemi, T.
AddPirttiniemi, P(ertti)
AddPuistola, U(lla)
AddRajaniemi, H.J.
AddRämet, M(ika)
AddRäsänen, P.
AddRaustia, A.
AddRemes, A(nne)
AddRisteli, J.
AddRistiniemi, J.
AddRuddock, L.W.
AddRuokonen, A.
AddRuskoaho, H.
AddRyynänen, M.
AddSaarakkala, S.
AddSaari, A.
AddSalo, T(uula)
AddSándor, G(eorge) K.
AddSavolainen, E-R.
AddSavolainen, M.J.
AddSavolainen, O.
AddSillanpää, M(ikko).
AddSoininen, R.
AddSorri, M.
AddTaanila, A.
AddTapiainen, T(erhi)
AddTervonen, O(smo)
AddTimonen, M(arkku)
AddTjäderhane, L.
AddTurpeenniemi-Hujanen, T.
AddTuukkanen, J(uha)
AddTuulonen, A.
AddUhari, M.
AddUkkola, O(lavi)
AddUusimaa, J.
AddVainio, O.
AddVainio, S.
AddVeijola, J(uha)
AddVeijola, R(iitta)
AddVirokannas, H.
AddVoipio, H(anna)-M(arja)
AddVuolteenaho, O.
AddWeckström, M.
AddWei, GH.
AddWierenga, R.K.
AddWinqvist, R.
AddYlänne, J.
AddYlitalo, K(ari)

Scholar Chart >>

»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:

Peptide Hormones and Risk for Future Cardiovascular Events among Prediabetics: A 20-Year Follow-Up in the Opera Study.Kesäniemi, Y.A.123 dayssaveRefWorks
Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study).Kesäniemi, Y.A.207 dayssaveRefWorks
The validity of hospital discharge register data on non-ST-elevation and ST-elevation myocardial infarction in Finland.Kesäniemi, Y.A.247 dayssaveRefWorks
Relation of Lipid-Lowering Therapy to Need for Aortic Valve Replacement in Patients With Asymptomatic Mild to Moderate Aortic Stenosis.Kesäniemi, Y.A.280 dayssaveRefWorks
Non-dipping blood pressure pattern and new-onset diabetes in a 21-year follow-up.Kesäniemi, Y.A.423 dayssaveRefWorks
Life style habits, biochemical factors and their interaction in the prediction of incident hypertension during 21-year follow-up.Kesäniemi, Y.A.593 dayssaveRefWorks
Title: Dietary Sodium Intake is Associated with Long-Term Risk of New-Onset Atrial Fibrillation.Kesäniemi, Y.A.603 dayssaveRefWorks
Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study).Kesäniemi, Y.A.646 dayssaveRefWorks
Effect of simvastatin and ezetimibe on suPAR levels and outcomes.Kesäniemi, Y.A.835 dayssaveRefWorks
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study.Kesäniemi, Y.A.863 dayssaveRefWorks
Increasing ambulatory pulse pressure predicts the development of left ventricular hypertrophy during long-term follow-up.Kesäniemi, Y.A.885 dayssaveRefWorks
Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study).Kesäniemi, Y.A.901 dayssaveRefWorks
IgA antibodies to phosphocholine associate with long-term cardiovascular disease risk.Kesäniemi, Y.A.929 dayssaveRefWorks
Case fatality of acute coronary events is improving even among elderly patients; the FINAMI study 1995-2012.Kesäniemi, Y.A.1026 dayssaveRefWorks
Ambulatory Pulse Pressure Predicts the Development of Left Ventricular Diastolic Dysfunction in Over 20 Years of Follow-up.Kesäniemi, Y.A.1031 dayssaveRefWorks
Cardiac Remodeling from Middle Age to Senescence.Kesäniemi, Y.A.1126 dayssaveRefWorks
A Low-Frequency Inactivating Akt2 Variant Enriched in the Finnish Population is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk.Kesäniemi, Y.A.1203 dayssaveRefWorks
Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.Kesäniemi, Y.A.1217 dayssaveRefWorks
Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention.Kesäniemi, Y.A.1232 dayssaveRefWorks
Decreased mortality risk due to first acute coronary syndrome in women with postmenopausal hormone therapy use.Kesäniemi, Y.A.1341 dayssaveRefWorks
SuPAR Predicts Cardiovascular Events and Mortality in Patients With Asymptomatic Aortic Stenosis.Kesäniemi, Y.A.1434 dayssaveRefWorks
Assessing Optimal Blood Pressure in Patients with Asymptomatic Aortic Valve Stenosis: The SEAS Study.Kesäniemi, Y.A.1438 dayssaveRefWorks
Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes.Kesäniemi, Y.A.1455 dayssaveRefWorks
Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).Kesäniemi, Y.A.1700 dayssaveRefWorks
Predictors of Development of Echocardiographic Left Ventricular Diastolic Dysfunction in the Subjects Aged 40 to 59 Years (from the Oulu Project Elucidating Risk of Atherosclerosis Study).Kesäniemi, Y.A.1772 dayssaveRefWorks
Dietary sodium intake and prediction of cardiovascular events.Kesäniemi, Y.A.1936 dayssaveRefWorks
High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy.Kesäniemi, Y.A.1973 dayssaveRefWorks
Incidence of Cancer and Mortality in Patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Trial.Kesäniemi, Y.A.2112 dayssaveRefWorks
High plasma ghrelin protects from coronary heart disease and Leu72Leu polymorphism of ghrelin gene from cancer in healthy adults during the 19 years follow-up study.Kesäniemi, Y.A.2116 dayssaveRefWorks
Prognostic Significance of Impaired Baroreflex Sensitivity Assessed from Phase IV of the Valsalva Maneuver in a Population-Based Sample of Middle-Aged Subjects.Kesäniemi, Y.A.2192 dayssaveRefWorks
Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.Kesäniemi, Y.A.2305 dayssaveRefWorks
Heart Rate Variability Findings as a Predictor of Atrial Fibrillation in Middle-Aged Population.Kesäniemi, Y.A.2317 dayssaveRefWorks
Circulating cell-free DNA is associated with cardiometabolic risk factors: The Health 2000 Survey.Kesäniemi, Y.A.2337 dayssaveRefWorks
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report.Kesäniemi, Y.A.2337 dayssaveRefWorks
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia: Executive summary.Kesäniemi, Y.A.2357 dayssaveRefWorks
An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia.Kesäniemi, Y.A.2362 dayssaveRefWorks
Leptin Receptor Arg109 Homozygotes Display Decreased Total Mortality as well as Lower Incidence of Cardiovascular Disease and Related Death.Kesäniemi, Y.A.2456 dayssaveRefWorks
Plasma IgA antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes.Kesäniemi, Y.A.2460 dayssaveRefWorks
Long-term fructose feeding changes the expression of leptin receptors and autophagy genes in the adipose tissue and liver of male rats: a possible link to elevated triglycerides.Kesäniemi, Y.A.2475 dayssaveRefWorks
Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events.Kesäniemi, Y.A.2477 dayssaveRefWorks
Metabolic syndrome in the prediction of cardiovascular events: The potential additive role of hsCRP and adiponectin.Kesäniemi, Y.A.2578 dayssaveRefWorks
Peptide hormones in infants with feeding disorders.Kesäniemi, Y.A.2616 dayssaveRefWorks
Aging of the population may not lead to an increase in the numbers of acute coronary events: a community surveillance study and modelled forecast of the future.Kesäniemi, Y.A.2641 dayssaveRefWorks
A Blood Pressure Genetic Risk Score Is a Significant Predictor of Incident Cardiovascular Events in 32 669 Individuals.Kesäniemi, Y.A.2672 dayssaveRefWorks
Target organ damage and masked hypertension in the general population: the Finn-Home study.Kesäniemi, Y.A.2684 dayssaveRefWorks
Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR<sup>-/-</sup> mice and bind plasma autoantibodies in humans under enhanced carbamylation.Kesäniemi, Y.A.2736 dayssaveRefWorks
Long telomeres in blood leukocytes are associated with a high risk of ascending aortic aneurysm.Kesäniemi, Y.A.2777 dayssaveRefWorks
Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk.Kesäniemi, Y.A.2792 dayssaveRefWorks
Fish consumption, omega-3 fatty acids, and environmental contaminants in relation to low-grade inflammation and early atherosclerosis.Kesäniemi, Y.A.2819 dayssaveRefWorks
High ambulatory blood pressure values associated with nonalcoholic fatty liver in middle-aged adults.Kesäniemi, Y.A.2869 dayssaveRefWorks
 XML / RSS feed
next »